Citigroup Maintains Buy on Intuitive Surgical, Lowers Price Target to $390
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Joanne Wuensch maintains a 'Buy' rating on Intuitive Surgical (NASDAQ:ISRG) but has lowered the price target from $400 to $390.

October 20, 2023 | 4:14 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Citigroup maintains a 'Buy' rating on Intuitive Surgical but lowers the price target from $400 to $390.
While the 'Buy' rating is maintained, the lowering of the price target could indicate a slightly less optimistic outlook for the company's stock in the short term. However, the impact is likely to be neutral as the rating is still 'Buy'.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100